A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Clinical trial NCT06622226 · TERMINATED

Trial details

NCT number: NCT06622226
Sponsor: Ono Pharmaceutical Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Hodgkin Lymphoma

Start date: 2024-11-27
Primary completion: 2026-04-28
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.